Jm. Kent et al., CLINICAL UTILITY OF THE SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN THE SPECTRUM OF ANXIETY, Biological psychiatry, 44(9), 1998, pp. 812-824
The selective serotonin reuptake inhibitors (SSRIs) are now being empl
oyed in the treatment of the full spectrum of anxiety, disorders. In c
omparative trials, the SSRIs are proving to be equal or superior in ef
ficacy to traditional antianxiety medications. Due to their favorable
side effect profile, safety, and tolerability, they are rapidly replac
ing older agents in the treatment of anxiety. Neuroanatomical pathways
that may be important in the antianxiety effect of the SSRIs are outl
ine and discussed followed by a review of the clinical evidence suppor
ting the efficacy of this class of medications in the treatment of anx
iety disorders. (C) 1998 Society of Biological Psychiatry.